Cart
sales@molnova.com
Home - Products - Others - Other Targets - DCZ3301

DCZ3301

CAS No. 2136278-38-9

DCZ3301( —— )

Catalog No. M37649 CAS No. 2136278-38-9

DCZ3301 is a novel aryl-guanidino inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 169 In Stock
5MG 153 In Stock
10MG 225 In Stock
25MG 337 In Stock
50MG 465 In Stock
100MG 625 In Stock
200MG 828 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    DCZ3301
  • Note
    Research use only, not for human use.
  • Brief Description
    DCZ3301 is a novel aryl-guanidino inhibitor.
  • Description
    DCZ3301 is a potent aryl-guanidino inhibitor. DCZ3301 inhibits cell proliferation, induces G2/M cell cycle arrest and apoptosis. DCZ3301 inhibits the activation of the PI3K/AKT pathway by downregulating the protein expression of PI3K and phosphorylation of AKT. DCZ3301 can be used in research of cancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2136278-38-9
  • Formula Weight
    464.83
  • Molecular Formula
    C20H16ClF3N6O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O(C=1C=C(C(NC)=O)N=CC1)C=2C=CC(NC(NC3=CC(C(F)(F)F)=C(Cl)C=C3)=N)=NC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Xiao W, et, al. DCZ3301, a novel aryl-guanidino inhibitor, induces cell apoptosis and cell cycle arrest via suppressing the PI3K/AKT pathway in T-cell leukemia/lymphoma. Acta Biochim Biophys Sin (Shanghai). 2018 Jul 1;50(7):643-650.?
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products
Sign In Join Free